Guerbet gets approval for contrast kit in Taiwan

By staff writers

February 6, 2020 -- The Taiwan Ministry of Health and Welfare has delivered registration for Guerbet's contrast media kit Vectorio.

Vectorio is a mixing and injection system for administering Guerbet's Lipiodol Ultra Fluid plus an anticancer drug during transarterial chemoembolization procedures. It is designed for adults with intermediate-stage hepatocellular carcinoma.

The system received the European CE Mark in August 2017 and officially launched in September 2017. It is currently registered in 25 countries.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking